Delivery Order SPE2DR25D3303-SPE2DR26F73V5
- Not listed
- The Defense Logistics Agency issued a $13,964.22 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for VIVITROL 380 mg vial-diluents with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense and...
- <p>The Defense Logistics Agency issued a $23,457.53 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $23,457.53 and ultimate completion date of March 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed price and was not issued under a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems.</p>
- The Defense Logistics Agency issued a $11,091.90 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for Vivitrol 380 mg vial-diluents under a firm fixed-price structure. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 3, 2026. No set-aside was used. The parent IDC is Cencora, Inc.'s (Amerisourcebergen's parent) $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, valued through December 2031, which supports...
- <p>The Defense Logistics Agency issued a $4,436.76 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Vivitrol 380 mg vial-diluents.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 19, 2026. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp operates under its parent organization, Cencora, Inc.</p>
- The Defense Logistics Agency issued a $6,894.94 delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for Vivitrol 380 mg vial-diluents with an ultimate completion date of April 1, 2026. The order is issued under the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent organization) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This vehicle supplies a comprehensive range of pharmaceutical products and medical commodities to...
- The Defense Logistics Agency awarded a delivery order valued at $6,655.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and completion scheduled for January 29, 2026. This is a firm fixed-price, non-set-aside contract awarded on a competitive basis. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across...
- The Defense Logistics Agency awarded a $11,558.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 30, 2025, and represents a single delivery order fulfilling pharmaceutical supply needs for the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,218.38 to Amerisourcebergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made on January 14, 2026, and represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- <p>The Defense Logistics Agency issued a $7,041.12 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Vivitrol 380 mg vial-diluents, with an ultimate completion date of March 16, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued under firm fixed-price terms with no set-aside.</p>
- The Defense Logistics Agency awarded a $4,569.98 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents on January 14, 2026, with completion targeted for January 15, 2026. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken,...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F73V5Delivery Order
The Defense Logistics Agency issued a $7,971.54 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for Vivitrol 380 mg vials and diluents, with an ultimate completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed-price under a full-and-open competitive award with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to the Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 4/20/26 |